Palladone Approval History
- FDA approved: Yes (First approved September 24th, 2004)
- Brand name: Palladone
- Generic name: hydromorphone hydrochloride
- Dosage form: Extended Release Capsules
- Company: Purdue Pharma L.P.
- Treatment for: Pain
Palladone (hydromorphone hydrochloride) is an extended release opioid analgesic indicated for the management of persistent, moderate to severe pain in patients requiring continuous, around-the-clock opioid analgesia with a high potency opioid for an extended period of time.
Development History and FDA Approval Process for Palladone
|Sep 24, 2004||Palladone Purdue Pharma L.P. - Treatment for Moderate to Severe Pain|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.